ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 114 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $184,040 | -16.4% | 37,255 | +6.4% | 0.01% | -21.4% |
| Q4 2022 | $220,175 | -38.7% | 35,004 | +5.2% | 0.01% | -39.1% |
| Q3 2022 | $359,000 | -18.6% | 33,282 | -13.9% | 0.02% | 0.0% |
| Q2 2022 | $441,000 | +58.6% | 38,648 | +26.8% | 0.02% | +53.3% |
| Q1 2022 | $278,000 | -24.0% | 30,470 | +24.1% | 0.02% | -31.8% |
| Q4 2021 | $366,000 | -52.5% | 24,559 | -18.2% | 0.02% | -48.8% |
| Q3 2021 | $771,000 | -6.7% | 30,012 | -5.2% | 0.04% | -2.3% |
| Q2 2021 | $826,000 | +17.5% | 31,666 | +59.1% | 0.04% | +10.0% |
| Q1 2021 | $703,000 | +24.2% | 19,909 | -11.3% | 0.04% | -2.4% |
| Q4 2020 | $566,000 | -83.2% | 22,444 | -74.8% | 0.04% | -62.4% |
| Q3 2020 | $3,362,000 | +45.3% | 89,163 | +65.0% | 0.11% | +81.7% |
| Q2 2020 | $2,314,000 | +147.0% | 54,040 | +12.1% | 0.06% | +140.0% |
| Q1 2020 | $937,000 | -13.2% | 48,208 | +16.0% | 0.02% | +66.7% |
| Q4 2019 | $1,080,000 | – | 41,574 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $26,829,000 | 10.04% |
| Wildcat Capital Management, LLC | 1,716,370 | $25,608,000 | 4.17% |
| TPG GP A, LLC | 18,716,306 | $279,247,000 | 2.79% |
| Casdin Capital, LLC | 2,650,000 | $39,538,000 | 1.11% |
| Lombard Odier Asset Management (Switzerland) SA | 996,116 | $14,862,000 | 0.95% |
| Coastal Bridge Advisors, LLC | 301,929 | $4,505,000 | 0.94% |
| HARBOR CAPITAL ADVISORS, INC. | 119,547 | $1,784,000 | 0.65% |
| Pier Capital, LLC | 294,968 | $4,401,000 | 0.46% |
| Navalign, LLC | 64,428 | $961,000 | 0.38% |
| Gratus Capital, LLC | 191,871 | $2,863,000 | 0.26% |